Glial role in oxaliplatin-induced neuropathic pain

2014/06/24 by Lorenzo Di Cesare Mannelli, Alessandra Pacini, Laura Micheli +3 · 26 citations
Medicine · Pharmacology, Toxicology and Pharmaceutics · #Cancer Treatment and Pharmacology #Pain Mechanisms and Treatments #Plant-based Medicinal Research

paper · doi:10.1016/j.expneurol.2014.06.016

Cited by

• Neuroimmunology of Behavioral Comorbidities Associated With Cancer and Cancer Treatments
• Delay of morphine tolerance by palmitoylethanolamide. [europepmc]
• Mechanisms of chemotherapy-induced behavioral toxicities. [europepmc]
• Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicity. [europepmc]
• Exenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in Rats. [europepmc]
• Metformin Prevents Cisplatin-Induced Cognitive Impairment and Brain Damage in Mice. [europepmc]
• The Suppressive Effects of Cinnamomi Cortex and Its Phytocompound Coumarin on Oxaliplatin-Induced Neuropathic Cold Allodynia in Rats. [europepmc]
• Anti-allodynic effect of Buja in a rat model of oxaliplatin-induced peripheral neuropathy via spinal astrocytes and pro-inflammatory cytokines suppression. [europepmc]
• Neuroimmune mechanisms of behavioral alterations in a syngeneic murine model of human papilloma virus-related head and neck cancer. [europepmc]
• Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy. [europepmc]
• Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN). [europepmc]
• Neuroimmunology of Behavioral Comorbidities Associated With Cancer and Cancer Treatments. [europepmc]
• Gut microbiota-immune-brain interactions in chemotherapy-associated behavioral comorbidities. [europepmc]
• Methotrexate causes persistent deficits in memory and executive function in a juvenile animal model. [europepmc]
• Mechanisms of Chemotherapy-Induced Peripheral Neuropathy. [europepmc]
• Cannabinoids: Current and Future Options to Treat Chronic and Chemotherapy-Induced Neuropathic Pain. [europepmc]
• Chemokine Signaling in Chemotherapy-Induced Neuropathic Pain. [europepmc]
• Recent advances in understanding chemotherapy-induced peripheral neuropathy. [europepmc]
• Acute visceral pain relief mediated by A3AR agonists in rats: involvement of N-type voltage-gated calcium channels. [europepmc]
• Management of Oxaliplatin-Induced Peripheral Sensory Neuropathy. [europepmc]
• The Role of Satellite Glial Cells, Astrocytes, and Microglia in Oxaliplatin-Induced Neuropathic Pain. [europepmc]
• Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence. [europepmc]
• Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy. [europepmc]
• Oxaliplatin-Induced Neuropathy: Genetic and Epigenetic Profile to Better Understand How to Ameliorate This Side Effect. [europepmc]
• Reactive Astrocytes: Critical Players in the Development of Chronic Pain. [europepmc]
• VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody. [europepmc]